Department of Global Health, University of Washington, Seattle, United States.
Division of Life Sciences, Natural History Museum, London, United Kingdom.
PLoS Negl Trop Dis. 2018 Jan 18;12(1):e0005988. doi: 10.1371/journal.pntd.0005988. eCollection 2018 Jan.
Hybrid trials that include both clinical and implementation science outcomes are increasingly relevant for public health researchers that aim to rapidly translate study findings into evidence-based practice. The DeWorm3 Project is a series of hybrid trials testing the feasibility of interrupting the transmission of soil transmitted helminths (STH), while conducting implementation science research that contextualizes clinical research findings and provides guidance on opportunities to optimize delivery of STH interventions. The purpose of DeWorm3 implementation science studies is to ensure rapid and efficient translation of evidence into practice. DeWorm3 will use stakeholder mapping to identify individuals who influence or are influenced by school-based or community-wide mass drug administration (MDA) for STH and to evaluate network dynamics that may affect study outcomes and future policy development. Individual interviews and focus groups will generate the qualitative data needed to identify factors that shape, contextualize, and explain DeWorm3 trial outputs and outcomes. Structural readiness surveys will be used to evaluate the factors that drive health system readiness to implement novel interventions, such as community-wide MDA for STH, in order to target change management activities and identify opportunities for sustaining or scaling the intervention. Process mapping will be used to understand what aspects of the intervention are adaptable across heterogeneous implementation settings and to identify contextually-relevant modifiable bottlenecks that may be addressed to improve the intervention delivery process and to achieve intervention outputs. Lastly, intervention costs and incremental cost-effectiveness will be evaluated to compare the efficiency of community-wide MDA to standard-of-care targeted MDA both over the duration of the trial and over a longer elimination time horizon.
混合试验既包括临床结果,也包括实施科学结果,对于旨在迅速将研究结果转化为基于证据的实践的公共卫生研究人员来说越来越重要。DeWorm3 项目是一系列混合试验,旨在测试中断土壤传播性蠕虫(STH)传播的可行性,同时开展实施科学研究,使临床研究结果背景化,并提供有关优化 STH 干预措施提供机会的指导。DeWorm3 实施科学研究的目的是确保迅速有效地将证据转化为实践。DeWorm3 将利用利益相关者图谱来确定影响或受学校或社区范围大规模药物管理(MDA)影响的个人,以评估可能影响研究结果和未来政策制定的网络动态。个人访谈和焦点小组将生成定性数据,以确定影响 DeWorm3 试验结果和结果的因素。结构准备度调查将用于评估驱动卫生系统准备实施新型干预措施(如社区范围 MDA 治疗 STH)的因素,以便针对变更管理活动,并确定维持或扩大干预措施的机会。流程映射将用于了解干预措施的哪些方面在异构实施环境中具有适应性,并确定可能需要解决的与上下文相关的可修改瓶颈,以改善干预措施的提供过程,并实现干预措施的结果。最后,将评估干预措施的成本和增量成本效益,以比较社区范围 MDA 与标准护理靶向 MDA 的效率,无论是在试验期间还是在更长的消除时间范围内。